Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Otolaryngology · Ménière's disease

How Common Are Endolymphatic Hydrops and Ménière's Disease?

At a Glance

Clinically diagnosed Ménière’s disease affects about 0.05% to 0.2% of adults, but endolymphatic hydrops can also appear on MRI without symptoms. An MRI finding alone cannot diagnose Ménière’s disease; symptom history and hearing tests are essential.

Key takeaway: A scan showing fluid buildup (hydrops) is not the same as having symptomatic Ménière’s disease. Furthermore, finding hydrops in your opposite, symptom-free ear does not necessarily mean that ear will eventually develop the disease [1][2].

Clinically diagnosed Ménière’s disease is relatively uncommon. Published population studies estimate it affects roughly 0.05% to 0.2% of adults (about 50 to 200 out of every 100,000 people) [3]. However, this is an approximation, and exact estimates vary depending on the country, the population studied, and the specific diagnostic definitions used [3][4]. Statistical estimates of prevalence fluctuate in part because medical guidelines have changed over time, such as the shift from older 1995 frameworks to current criteria [5][4].

Ménière’s Disease vs. MRI-Detected Hydrops

Endolymphatic hydrops refers to an abnormal expansion of fluid in the inner ear spaces (not the middle ear) [6]. While it is frequently associated with Ménière’s disease, the two are not the same thing.

Ménière’s disease is diagnosed based on clinical consensus criteria—currently, the 2015 international criteria formulated by the Bárány Society [7]. These criteria classify the disease as either “definite” or “probable” [7]. A “definite” diagnosis requires a specific history of episodic vertigo and fluctuating ear symptoms, plus objective proof of low- to medium-frequency sensorineural hearing loss on a clinical hearing test (audiometry) [8][7].

Endolymphatic hydrops is an associated finding that may contribute to symptoms, but it is neither necessary nor sufficient to make a diagnosis [6][1]. The distinction is important for several reasons:

  • Hydrops is common in people without Ménière’s disease: While specialized inner-ear MRI scans detect hydrops in about 82% of patients with definite or probable Ménière’s disease, they also find it in people with other conditions, like vestibular migraine [1].
  • Hydrops can be completely asymptomatic: Specialized MRI studies have found incidental hydrops in 7% of healthy volunteers in one specific cohort [9], while a broader literature review found an average rate of 31% among healthy control subjects [1].
  • Imaging findings can change: Sometimes, incidental fluid buildup discovered on a scan will simply disappear over time [9]. However, this apparent resolution on a scan does not guarantee that the finding was harmless, nor does it mean an established clinical case of Ménière’s disease is cured [9].

Finding hydrops on a dedicated scan can support a doctor’s diagnosis, but it cannot confirm it and does not replace a careful clinical history and audiogram [6].

Who Is Most Likely to Develop It?

Anyone can develop Ménière’s disease [10]. Age and sex patterns merely describe groups; they cannot be used to confirm or rule out a diagnosis for you as an individual [10].

  • Age: The condition is predominantly diagnosed in middle to later adulthood [10]. Extensive population registries show the average age at diagnosis is typically between 55 and 60 years old [10][11][12].
  • Sex: Women form a modest majority of cases [10]. In large registry studies, women make up about 54% to 65% of those diagnosed [10][11].

Does It Affect One Ear or Both?

Ménière’s disease usually starts in just one ear [13]. Bilateral Ménière’s disease (experiencing clinical symptoms in both ears) is reported in roughly 5% to 15% of patients in specific clinical cohorts [13][14][15]. These numbers can vary significantly based on how long patients are followed [13].

When clinical symptoms do develop in both ears, they usually happen sequentially rather than at the same time [16]. One clinical study found a median time of 7 years before the second ear developed symptoms, though this is a cohort average, not a specific prediction for your individual risk [16].

It is understandable to worry about the health of your other ear. Interestingly, in patients with one-sided Ménière’s disease, MRI scans sometimes reveal endolymphatic hydrops in their opposite, “healthy” ear—occurring in about 23% to 24% of these asymptomatic ears [2]. But just as in healthy populations, this imaging finding alone does not automatically mean you will develop clinical symptoms in that second ear [2][17].

Diagnostic Monitoring

Because symptoms overlap with other conditions, a diagnosis may be revised over time as the disease evolves [7]. Monitoring your condition usually involves baseline and follow-up audiograms as directed by your clinician, and carefully tracking which ear is experiencing symptoms [7].

Safety Note: Sudden hearing loss, new neurologic symptoms, or severe continuous vertigo can sometimes mimic Ménière’s disease but require prompt medical assessment to rule out other causes [7].

Common questions in this guide

How common is clinically diagnosed Ménière’s disease?
Clinically diagnosed Ménière’s disease affects an estimated 0.05% to 0.2% of adults, or about 50 to 200 people per 100,000. Estimates differ among countries and studies because the populations and diagnostic criteria vary.
Does endolymphatic hydrops on an MRI mean I have Ménière’s disease?
No. Hydrops is an expansion of fluid spaces in the inner ear that can be seen in people with Ménière’s disease, other conditions, or no symptoms. The diagnosis depends on your symptom history and hearing test; MRI can support the assessment but cannot confirm it by itself.
Can someone have endolymphatic hydrops without symptoms?
Yes. Specialized MRI studies have found hydrops in some healthy volunteers and in people with conditions such as vestibular migraine. Reported rates vary, from 7% in one healthy volunteer group to an average of 31% across a broader review, and a later-normal scan does not prove the original finding was harmless.
How often does Ménière’s disease affect both ears?
Clinical symptoms in both ears are reported in roughly 5% to 15% of patients, although estimates depend on how long people are followed. When the second ear becomes affected, it usually happens later rather than at the same time; one study found a median interval of 7 years, which is not an individual prediction.
Does hydrops in my symptom-free ear mean I will develop Ménière’s disease there?
Not necessarily. In people with one-sided Ménière’s disease, hydrops has been seen on MRI in about 23% to 24% of symptom-free opposite ears, but this imaging finding alone does not show that clinical disease will develop. Symptoms and hearing tests over time are more important for monitoring.
Who is most likely to be diagnosed with Ménière’s disease?
Anyone can develop it, but population studies diagnose it most often in middle to later adulthood, with the average age at diagnosis around 55 to 60 years. Women make up about 54% to 65% of cases in some large registries. These patterns describe groups and cannot confirm or rule out the condition in one person.
How is Ménière’s disease monitored over time?
Clinicians commonly use a baseline hearing test and follow-up audiograms, along with a record of which ear has symptoms and how episodes change. The diagnosis may be revised as symptoms evolve because vertigo and hearing changes overlap with other conditions. Sudden hearing loss, new neurologic symptoms, or severe continuous vertigo need prompt medical assessment.

Get notified when new evidence is published on endolymphatic hydrops.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    The "hype" of hydrops in classifying vestibular disorders: a narrative review.

    van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.

    Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.

    PMID: 33201310
  2. 2

    Endolymphatic hydrops in contralateral ear of patients with unilateral Meniere's disease.

    Wang J, Huang Y, Zhao P, et al.

    Acta oto-laryngologica 2026; (146(4)):500-507 doi:10.1080/00016489.2026.2613137.

    PMID: 41636232
  3. 3

    Epidemiological and clinical differences in Meniere disease across European and East Asian populations.

    Lopez-Escamez JA, Xu M, Zhang Q, Tsang BK

    The Journal of international medical research 2026; (54(8)):3000605261473157 doi:10.1177/03000605261473157.

    PMID: 42545183
  4. 4

    What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.

    Gürkov R, Pyykö I, Zou J, Kentala E

    Journal of neurology 2016; (263 Suppl 1()):S71-81 doi:10.1007/s00415-015-7930-1.

    PMID: 27083887
  5. 5

    2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Ménière's Disease.

    Goebel JA

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2016; (154(3)):403-4 doi:10.1177/0194599816628524.

    PMID: 26884364
  6. 6

    Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

    Sousa R, Raposo F, Guerreiro C, et al.

    Neuroradiology 2021; (63(11)):1749-1763 doi:10.1007/s00234-021-02744-5.

    PMID: 34142211
  7. 7

    On the classification of hydropic ear disease (Menière's disease).

    Gürkov R, Hornibrook J

    HNO 2018; (66(6)):455-463 doi:10.1007/s00106-018-0488-3.

    PMID: 29500497
  8. 8

    Menière and Friends: Imaging and Classification of Hydropic Ear Disease.

    Gürkov R

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(10)):e539-e544 doi:10.1097/MAO.0000000000001479.

    PMID: 29135874
  9. 9

    Prognosis of asymptomatic endolymphatic hydrops in healthy volunteers: A five-year cohort study.

    Kimura T, Kitahara T, Okayasu T, et al.

    Laryngoscope investigative otolaryngology 2024; (9(6)):e70026 doi:10.1002/lio2.70026.

    PMID: 39525523
  10. 10

    Population-Based Study on the Epidemiology of Ménière's Disease.

    Bruderer SG, Bodmer D, Stohler NA, et al.

    Audiology & neuro-otology 2017; (22(2)):74-82 doi:10.1159/000475875.

    PMID: 28723686
  11. 11

    Epidemiology, Health Care Utilization, and Employment Status in Ménière Disease: A Danish Register-based Cohort Study From 1995 to 2019.

    Grønlund C, Devantier L, Karlberg M, Djurhuus BD

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2025; (46(10)):e511-e518 doi:10.1097/MAO.0000000000004631.

    PMID: 41145394
  12. 12

    Long-term economic and welfare consequences of Ménière's disease: a Danish nationwide matched cohort study, 2002-2016.

    Grønlund C, Möller S, Christensen HC, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(7)):4287-4296 doi:10.1007/s00405-026-10140-z.

    PMID: 42086989
  13. 13

    Characteristics of clinical details and endolymphatic hydrops in unilateral and bilateral Ménière's disease in a single Asian group.

    Shi S, Li W, Wang D, et al.

    Frontiers in neurology 2022; (13()):964217 doi:10.3389/fneur.2022.964217.

    PMID: 36176561
  14. 14

    An Update on the Epidemiology and Clinicodemographic Features of Meniere's Disease.

    De Ravin E, Quimby AE, Bartellas M, et al.

    The Laryngoscope 2024; (134(7)):3310-3315 doi:10.1002/lary.31282.

    PMID: 38238895
  15. 15

    Clinical Characteristics of Bilateral Meniere's Disease in a Single Asian Ethnic Group.

    Suh MJ, Jeong J, Kim HJ, et al.

    The Laryngoscope 2019; (129(5)):1191-1196 doi:10.1002/lary.27423.

    PMID: 30284277
  16. 16

    Bilateral Ménière's disease according to its form of debut: synchronous and metachronous disease.

    Pérez-Carbonell T, Orts-Alborch M, Pla-Gil I, et al.

    The Journal of laryngology and otology 2023; (137(7)):782-788 doi:10.1017/S0022215122002262.

    PMID: 36200516
  17. 17

    Clinical Features and Endolymphatic Hydrops in Patients With MRI Evidence of Hydrops.

    Shi S, Guo P, Li W, Wang W

    The Annals of otology, rhinology, and laryngology 2019; (128(4)):286-292 doi:10.1177/0003489418819551.

    PMID: 30556402

This page explains population estimates and the difference between MRI-detected hydrops and Ménière's disease for informational purposes only and does not constitute medical advice. An ENT specialist or audiologist should interpret your symptoms, hearing tests, and scans.